Effect of Salt Form on Gelation and Drug Delivery Properties of Diclofenac-Loaded Poloxamer Gels for Delivery to Impaired Skin
Purpose Treating chronic wounds is a significant clinical challenge, and a topical product would be ideal for pain management. Poloxamer 407, a thermosensitive polymer, would allow an analgesic drug to be topically applied to a wound as a liquid that transitions to a gel at physiologic temperature....
Gespeichert in:
Veröffentlicht in: | Pharmaceutical research 2022-10, Vol.39 (10), p.2515-2527 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2527 |
---|---|
container_issue | 10 |
container_start_page | 2515 |
container_title | Pharmaceutical research |
container_volume | 39 |
creator | Russo, Jackson Fiegel, Jennifer Brogden, Nicole K. |
description | Purpose
Treating chronic wounds is a significant clinical challenge, and a topical product would be ideal for pain management. Poloxamer 407, a thermosensitive polymer, would allow an analgesic drug to be topically applied to a wound as a liquid that transitions to a gel at physiologic temperature. Using diclofenac as a model analgesic drug, our goal was to determine effects of salt form on poloxamer gelation and drug delivery from poloxamer gels applied to excised skin with impaired barrier function.
Methods
Gelation properties of 17% and 20% poloxamer gels loaded with 0.4 to 1.7% diclofenac sodium, potassium, epolamine, or diethylamine were evaluated rheologically. Drug release and delivery were quantified using cellulose membranes, porcine skin, and tape-stripped porcine skin.
Results
Poloxamer gelation temperature increased with higher diclofenac concentration, regardless of salt form; the magnitude of increase varied in the following order: sodium>potassium>diethylamine>epolamine. Gelation temperature differences resulting from the various counterions generally matched previously observed trends of ion-specific effects on macromolecule solubility (the Hofmeister series). Despite changes in gelation behavior, we observed minimal corresponding effects on drug release or delivery. There were no significant differences in diclofenac released or delivered through intact porcine skin over 48 h. However, in studies with impaired (tape-stripped) skin, diclofenac delivery was slowest overall with the epolamine salt.
Conclusion
Varying the salt form of a model analgesic drug can impact gelation and drug delivery characteristics of poloxamer systems. Further study of the mechanisms of these changes will be important for continued development of topical poloxamer products for clinical wound care. |
doi_str_mv | 10.1007/s11095-022-03356-1 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9578569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A722215639</galeid><sourcerecordid>A722215639</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-2f9899772c4a6e18a398f67fe24fb1839108f6cfb9947dc79673ad8d15d4461e3</originalsourceid><addsrcrecordid>eNp9kl9rFDEUxYModq1-AZ8CvvgyNf8mmbwIpdvWwoKFKvgWspmbNXUmWZPZYl_87Gbc4lIRyUNyk985NxcOQq8pOaGEqHeFUqLbhjDWEM5b2dAnaEFbxRtNxJenaEEUE02nBD1CL0q5JYR0VIvn6IhLQpikfIF-nnsPbsLJ4xs7TPgi5RGniC9hsFOoBxt7vMy7DV7CEO4g3-PrnLaQpwBlVi2DG5KHaF2zSraHHl-nIf2wI-TZpGCf8kE7JXw1bm3Ilbv5FuJL9MzbocCrh_0Yfb44_3T2oVl9vLw6O101rqXd1DCvO62VYk5YCbSzXHdeKg9M-DXtuKak1s6vtRaqd0pLxW3f9bTthZAU-DF6v_fd7tYj9A7ilO1gtjmMNt-bZIN5_BLDV7NJd0a3qmulrgZvHwxy-r6DMpkxFAfDYCOkXTFMEaloqzWr6Ju_0Nu0y7GOVykmSEcYFQdqYwcwIfpU-7rZ1JwqxhhtJZ_bnvyDqquHMbgUwYd6_0jA9gKXUykZ_J8ZKTFzasw-NaamxvxOjaFVxPeiUuG4gXz48X9UvwDlpsJD</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2724080214</pqid></control><display><type>article</type><title>Effect of Salt Form on Gelation and Drug Delivery Properties of Diclofenac-Loaded Poloxamer Gels for Delivery to Impaired Skin</title><source>SpringerLink Journals - AutoHoldings</source><creator>Russo, Jackson ; Fiegel, Jennifer ; Brogden, Nicole K.</creator><creatorcontrib>Russo, Jackson ; Fiegel, Jennifer ; Brogden, Nicole K.</creatorcontrib><description>Purpose
Treating chronic wounds is a significant clinical challenge, and a topical product would be ideal for pain management. Poloxamer 407, a thermosensitive polymer, would allow an analgesic drug to be topically applied to a wound as a liquid that transitions to a gel at physiologic temperature. Using diclofenac as a model analgesic drug, our goal was to determine effects of salt form on poloxamer gelation and drug delivery from poloxamer gels applied to excised skin with impaired barrier function.
Methods
Gelation properties of 17% and 20% poloxamer gels loaded with 0.4 to 1.7% diclofenac sodium, potassium, epolamine, or diethylamine were evaluated rheologically. Drug release and delivery were quantified using cellulose membranes, porcine skin, and tape-stripped porcine skin.
Results
Poloxamer gelation temperature increased with higher diclofenac concentration, regardless of salt form; the magnitude of increase varied in the following order: sodium>potassium>diethylamine>epolamine. Gelation temperature differences resulting from the various counterions generally matched previously observed trends of ion-specific effects on macromolecule solubility (the Hofmeister series). Despite changes in gelation behavior, we observed minimal corresponding effects on drug release or delivery. There were no significant differences in diclofenac released or delivered through intact porcine skin over 48 h. However, in studies with impaired (tape-stripped) skin, diclofenac delivery was slowest overall with the epolamine salt.
Conclusion
Varying the salt form of a model analgesic drug can impact gelation and drug delivery characteristics of poloxamer systems. Further study of the mechanisms of these changes will be important for continued development of topical poloxamer products for clinical wound care.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1007/s11095-022-03356-1</identifier><identifier>PMID: 36002613</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Analgesics ; Biochemistry ; Biomedical and Life Sciences ; Biomedical Engineering and Bioengineering ; Biomedicine ; Care and treatment ; Cellulose ; Diclofenac ; Drug delivery ; Evaluation ; Gelation ; Gels ; Medical Law ; Nonsteroidal anti-inflammatory drugs ; Original Research Article ; Pharmacology/Toxicology ; Pharmacy ; Potassium ; Salt ; Skin ; Transdermal medication ; Wounds ; Wounds and injuries</subject><ispartof>Pharmaceutical research, 2022-10, Vol.39 (10), p.2515-2527</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>COPYRIGHT 2022 Springer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-2f9899772c4a6e18a398f67fe24fb1839108f6cfb9947dc79673ad8d15d4461e3</citedby><cites>FETCH-LOGICAL-c518t-2f9899772c4a6e18a398f67fe24fb1839108f6cfb9947dc79673ad8d15d4461e3</cites><orcidid>0000-0001-6838-8847</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11095-022-03356-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11095-022-03356-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Russo, Jackson</creatorcontrib><creatorcontrib>Fiegel, Jennifer</creatorcontrib><creatorcontrib>Brogden, Nicole K.</creatorcontrib><title>Effect of Salt Form on Gelation and Drug Delivery Properties of Diclofenac-Loaded Poloxamer Gels for Delivery to Impaired Skin</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><description>Purpose
Treating chronic wounds is a significant clinical challenge, and a topical product would be ideal for pain management. Poloxamer 407, a thermosensitive polymer, would allow an analgesic drug to be topically applied to a wound as a liquid that transitions to a gel at physiologic temperature. Using diclofenac as a model analgesic drug, our goal was to determine effects of salt form on poloxamer gelation and drug delivery from poloxamer gels applied to excised skin with impaired barrier function.
Methods
Gelation properties of 17% and 20% poloxamer gels loaded with 0.4 to 1.7% diclofenac sodium, potassium, epolamine, or diethylamine were evaluated rheologically. Drug release and delivery were quantified using cellulose membranes, porcine skin, and tape-stripped porcine skin.
Results
Poloxamer gelation temperature increased with higher diclofenac concentration, regardless of salt form; the magnitude of increase varied in the following order: sodium>potassium>diethylamine>epolamine. Gelation temperature differences resulting from the various counterions generally matched previously observed trends of ion-specific effects on macromolecule solubility (the Hofmeister series). Despite changes in gelation behavior, we observed minimal corresponding effects on drug release or delivery. There were no significant differences in diclofenac released or delivered through intact porcine skin over 48 h. However, in studies with impaired (tape-stripped) skin, diclofenac delivery was slowest overall with the epolamine salt.
Conclusion
Varying the salt form of a model analgesic drug can impact gelation and drug delivery characteristics of poloxamer systems. Further study of the mechanisms of these changes will be important for continued development of topical poloxamer products for clinical wound care.</description><subject>Analgesics</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Biomedicine</subject><subject>Care and treatment</subject><subject>Cellulose</subject><subject>Diclofenac</subject><subject>Drug delivery</subject><subject>Evaluation</subject><subject>Gelation</subject><subject>Gels</subject><subject>Medical Law</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Original Research Article</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Potassium</subject><subject>Salt</subject><subject>Skin</subject><subject>Transdermal medication</subject><subject>Wounds</subject><subject>Wounds and injuries</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kl9rFDEUxYModq1-AZ8CvvgyNf8mmbwIpdvWwoKFKvgWspmbNXUmWZPZYl_87Gbc4lIRyUNyk985NxcOQq8pOaGEqHeFUqLbhjDWEM5b2dAnaEFbxRtNxJenaEEUE02nBD1CL0q5JYR0VIvn6IhLQpikfIF-nnsPbsLJ4xs7TPgi5RGniC9hsFOoBxt7vMy7DV7CEO4g3-PrnLaQpwBlVi2DG5KHaF2zSraHHl-nIf2wI-TZpGCf8kE7JXw1bm3Ilbv5FuJL9MzbocCrh_0Yfb44_3T2oVl9vLw6O101rqXd1DCvO62VYk5YCbSzXHdeKg9M-DXtuKak1s6vtRaqd0pLxW3f9bTthZAU-DF6v_fd7tYj9A7ilO1gtjmMNt-bZIN5_BLDV7NJd0a3qmulrgZvHwxy-r6DMpkxFAfDYCOkXTFMEaloqzWr6Ju_0Nu0y7GOVykmSEcYFQdqYwcwIfpU-7rZ1JwqxhhtJZ_bnvyDqquHMbgUwYd6_0jA9gKXUykZ_J8ZKTFzasw-NaamxvxOjaFVxPeiUuG4gXz48X9UvwDlpsJD</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Russo, Jackson</creator><creator>Fiegel, Jennifer</creator><creator>Brogden, Nicole K.</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6838-8847</orcidid></search><sort><creationdate>20221001</creationdate><title>Effect of Salt Form on Gelation and Drug Delivery Properties of Diclofenac-Loaded Poloxamer Gels for Delivery to Impaired Skin</title><author>Russo, Jackson ; Fiegel, Jennifer ; Brogden, Nicole K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-2f9899772c4a6e18a398f67fe24fb1839108f6cfb9947dc79673ad8d15d4461e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analgesics</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Biomedicine</topic><topic>Care and treatment</topic><topic>Cellulose</topic><topic>Diclofenac</topic><topic>Drug delivery</topic><topic>Evaluation</topic><topic>Gelation</topic><topic>Gels</topic><topic>Medical Law</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Original Research Article</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Potassium</topic><topic>Salt</topic><topic>Skin</topic><topic>Transdermal medication</topic><topic>Wounds</topic><topic>Wounds and injuries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Russo, Jackson</creatorcontrib><creatorcontrib>Fiegel, Jennifer</creatorcontrib><creatorcontrib>Brogden, Nicole K.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Russo, Jackson</au><au>Fiegel, Jennifer</au><au>Brogden, Nicole K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Salt Form on Gelation and Drug Delivery Properties of Diclofenac-Loaded Poloxamer Gels for Delivery to Impaired Skin</atitle><jtitle>Pharmaceutical research</jtitle><stitle>Pharm Res</stitle><date>2022-10-01</date><risdate>2022</risdate><volume>39</volume><issue>10</issue><spage>2515</spage><epage>2527</epage><pages>2515-2527</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><abstract>Purpose
Treating chronic wounds is a significant clinical challenge, and a topical product would be ideal for pain management. Poloxamer 407, a thermosensitive polymer, would allow an analgesic drug to be topically applied to a wound as a liquid that transitions to a gel at physiologic temperature. Using diclofenac as a model analgesic drug, our goal was to determine effects of salt form on poloxamer gelation and drug delivery from poloxamer gels applied to excised skin with impaired barrier function.
Methods
Gelation properties of 17% and 20% poloxamer gels loaded with 0.4 to 1.7% diclofenac sodium, potassium, epolamine, or diethylamine were evaluated rheologically. Drug release and delivery were quantified using cellulose membranes, porcine skin, and tape-stripped porcine skin.
Results
Poloxamer gelation temperature increased with higher diclofenac concentration, regardless of salt form; the magnitude of increase varied in the following order: sodium>potassium>diethylamine>epolamine. Gelation temperature differences resulting from the various counterions generally matched previously observed trends of ion-specific effects on macromolecule solubility (the Hofmeister series). Despite changes in gelation behavior, we observed minimal corresponding effects on drug release or delivery. There were no significant differences in diclofenac released or delivered through intact porcine skin over 48 h. However, in studies with impaired (tape-stripped) skin, diclofenac delivery was slowest overall with the epolamine salt.
Conclusion
Varying the salt form of a model analgesic drug can impact gelation and drug delivery characteristics of poloxamer systems. Further study of the mechanisms of these changes will be important for continued development of topical poloxamer products for clinical wound care.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>36002613</pmid><doi>10.1007/s11095-022-03356-1</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-6838-8847</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0724-8741 |
ispartof | Pharmaceutical research, 2022-10, Vol.39 (10), p.2515-2527 |
issn | 0724-8741 1573-904X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9578569 |
source | SpringerLink Journals - AutoHoldings |
subjects | Analgesics Biochemistry Biomedical and Life Sciences Biomedical Engineering and Bioengineering Biomedicine Care and treatment Cellulose Diclofenac Drug delivery Evaluation Gelation Gels Medical Law Nonsteroidal anti-inflammatory drugs Original Research Article Pharmacology/Toxicology Pharmacy Potassium Salt Skin Transdermal medication Wounds Wounds and injuries |
title | Effect of Salt Form on Gelation and Drug Delivery Properties of Diclofenac-Loaded Poloxamer Gels for Delivery to Impaired Skin |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T14%3A02%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Salt%20Form%20on%20Gelation%20and%20Drug%20Delivery%20Properties%20of%20Diclofenac-Loaded%20Poloxamer%20Gels%20for%20Delivery%20to%20Impaired%20Skin&rft.jtitle=Pharmaceutical%20research&rft.au=Russo,%20Jackson&rft.date=2022-10-01&rft.volume=39&rft.issue=10&rft.spage=2515&rft.epage=2527&rft.pages=2515-2527&rft.issn=0724-8741&rft.eissn=1573-904X&rft_id=info:doi/10.1007/s11095-022-03356-1&rft_dat=%3Cgale_pubme%3EA722215639%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2724080214&rft_id=info:pmid/36002613&rft_galeid=A722215639&rfr_iscdi=true |